Status:
COMPLETED
Phenotypic Properties in Individuals Affected With XLHED
Lead Sponsor:
Edimer Pharmaceuticals
Conditions:
X Linked Hypohidrotic Ectodermal Dysplasia
Eligibility:
All Genders
4+ years
Brief Summary
The current study design incorporates two previously developed, non-invasive approaches to characterize the phenotype of individuals affected with XLHED.
Detailed Description
The current study design incorporates two previously developed, non-invasive approaches to characterize the phenotype of individuals affected with XLHED. Facial 3-dimensional (3D) imaging will be crea...
Eligibility Criteria
Inclusion
- Females of original gender of age 18-45 years who are registered and attending the 2013 NFED Family Conference. This will include those at risk for XLHED and controls
- XLHED-affected males of original gender of age 4 yrs and up who are registered and attending the 2013 NFED Family Conference
- Provide informed consent/assent
Exclusion
- Subjects who are not able or are not willing to comply with the procedures of this protocol
- Subjects with any major medical problem that will prevent them from participating in this study
- Male subjects who participated in the prior study ECP-003 sponsored by Edimer Pharmaceuticals Inc. in May 2011 in San Francisco, CA
- Males at risk for XLHED with prior genetic testing that did not reveal an EDA mutation
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01871714
Start Date
May 1 2013
End Date
September 1 2013
Last Update
November 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Omni Houston Hotel
Houston, Texas, United States, 77056